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Abstract We have set up a model system for familial 
amyotrophic lateral sclerosis (FALS) by transfecting human 
neuroblastoma cell line SH-SY5Y with plasmids directing 
constitutive xpression of either wild-type human Cu,Zn super- 
oxide dismutase (Cu,ZnSOD) or a mutant of this enzyme 
(G93A) associated with FALS. We have tested mitochondrial 
function and determined cytosolic Ca 2+ concentration in control 
cells (untransfected) and in cells expressing either wild-type 
Cu,ZnSOD or G93A. We report that G93A induces a significant 
loss of mitochondrial membrane potential, an increased sensitiv- 
ity toward valinomycin and a parallel increase in cytosolic Ca 2+ 
concentration. The above phenomena re not related to total 
Cu, ZnSOD content and activity in the cell. 
© 1997 Federation of European Biochemical Societies. 
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I. Introduction 
Amyotrophic lateral sclerosis (ALS) is a progressive, lethal 
disease characterized by degeneration of cortical and spinal 
motoneurons. 120 years after Charcot's original description, 
many of the mechanisms underlying this pathology are still 
poorly understood. 
ALS occurs both sporadically (SALS) and as a familial, 
age-dependent autosomal dominant disorder; more than 50 
point mutations in the gene encoding human Cu,Zn super- 
oxide dismutase (Cu,ZnSOD) have been reported to be re- 
sponsible for familial amyotrophic lateral sclerosis (FALS) 
[1,2]. Most autosomal-dominant FALS cases are indistin- 
guishable from SALS on the basis of clinical and pathologic 
criteria [3]. This similarity suggests that sporadic and familial 
forms share similar pathogenetic mechanisms. However, little 
is known about those mechanisms which would explain how 
the mutant SODs might result in motoneuron i jury. Present 
evidence indicates that ALS is a multifactorial disease [4] in 
which selective loss of motoneurons reflects a complex inter- 
play among oxidative injury, excitotoxic stimulation of the 
motoneuron and dysfunction of critical proteins uch as neu- 
rofilaments [5]. Furthermore, failure of calcium homeostasis 
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seems to play a central role among the mechanisms presum- 
ably involved in the pathogenesis of ALS; low levels of Ca 2+ 
binding proteins have been detected in human motoneurons 
[6,7]; increased Ca 2+ concentration is present in ALS patients 
[7] and many sporadic ALS patients possess erum antibodies 
to both L-type and P-type calcium channels [4,8] which are 
able to increase calcium entry in a motoneuron cell line [9]. 
Mitochondrial damage seems also to be involved, since alter- 
ations of these organelles have been reported in transgenic 
mice overexpressing mutant SOD [10] and changes in the ac- 
tivities of the mitochondrial e ectron transport chain complex 
I have been reported in FALS patients [3]. 
In order to investigate whether such cellular alterations 
might be associated with the presence of mutated Cu,ZnSODs 
in vivo, we have undertaken the construction of a cellular 
model system. Mutation G93A, one of those found in 
FALS families, has been introduced in the cDNA encoding 
human Cu,ZnSOD; this particular mutation has been chosen 
since it does not affect superoxide dismutase activity [23]. 
Several neuroblastoma cell lines have been established ex- 
pressing constitutively either wild-type Cu,ZnSOD or the mu- 
tant enzyme. We have begun investigating alterations induced 
by FALS superoxide dismutases by determining modifications 
of mitochondria and cytosolic Ca 2+ levels in these cell lines. 
2. Materials and methods 
2.1. Site-directed mutagenesis and chining in expression vectors ~/ 
Cu, Zn superoxide dismutase cDNAs 
Plasmid pEMBLHSOD containing the hSODwt coding region was 
used to generate single stranded DNA molecules to b  us din oligo- 
nucleotide-directed mutagenesis experiments as previously described 
[ll]. 
cDNAs coding for wild-type and FALS SODs were then subcloned 
in expression vector pRc/CMV (Invitrogen) by PCR using oligonu- 
cleotides SOD1 (5'-GCAAGCTTATGGCTAAAGCTGTG-3') and 
SOD2 (5'-GCGGGCCCTTATTGGGCGATCCCAAT-3') as pri- 
mers. 
All clones were routinely verified by determination of heir com- 
plete coding nucleotide sequences with Sequenase2 (USB). 
2.2. Establishment and characterization f transfected cell lines 
Human neuroblastoma SH-SY5Y cells were purchased from the 
European Collection f Cell Culture and grown in Dulbecco's 
M EM-F12 (Gibco) supplemented with 15% fetal calf serum, at 37°C 
in an atmosphere of 5% CO2 in air. 
Supercoiled plasmid DNA was purified by centrifugation on CsCI 
gradients essentially according to Sambrook et al:. [12]and was intro- 
duced into cell cultures (10 gg for 5×10 ~ cells) as a calcium-phos- 
phate precipitate [13]. 
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Monoclonal cell lines were obtained by selection of cells in growth 
medium containing 500 lag/ml geneticin (G418 sulfate, Gibco) and 
manual isolation of clones; after selection the geneticin concentration 
was kept at 200 lag/ml. Extracts were obtained by disruption of cells 
through repeated freezing at -70°C and thawing, followed by centri- 
fugation at 17000×g for 10 min. Supernatants were assayed for 
superoxide dismutase activity by the pyrogallol method at pH 8.2 
[14] or by staining of non-denaturing discontinuous PAGE [15] ac- 
cording to Beauchamp and Fridovich [16]. Protein was determined 
according to Lowry et al. [17]. Evaluation of immunoreactive Cu,Zn- 
SOD was obtained by densitometric s anning of Western blots, per- 
formed on cell supernatants run on 12.5% SDS-PAGE using Immun- 
blot kit from Bio-Rad and polyclonal antibodies against human 
Cu,ZnSOD raised in rabbits [18]. 
2.3. Determination of mitochondrial membrane depolarization 
Changes in mitochondrial membrane potential were monitored in 
cells by determining the shift in fluorescence mission of the dye JC-I 
(Molecular Probes, Eugene, OR). Depending upon the presence of an 
intact electrochemical gradient, JC-I is able to form J-aggregates that 
are associated with a shift from green to orange fluorescence [19]. The 
electrochemical membrane potential was monitored by treating intact 
cells in suspension with JC-1 (10 lag/ml), progressively abolished by 
addition of valinomycin (0-5 laM) and determining FL2 fluorescence 
shift in a Facscan cytometer (Becton Dickinson) equipped with a 
standard filter set for green (530/30 nm) and orange (585/42 nm) 
emission [20]. 
2.4. Determination of intracellular calcium concentration 
Control and transfected cell lines grown to about 70% confluence 
were incubated in growth media containing 1% FCS and 3 I.tM fluo- 
3AM (Molecular Probes) for 20 min at 25°C in the dark and then for 
a further 20 min at 37°C in the same conditions. After incubation with 
the fluorochrome, cultures were washed once in PBS and twice in 
HEPES saline; cells were then mechanically removed from the flask 
surface by repeated pipetting in HEPES saline, incubated for 10 min 
at 37°C and then directly tested for fluo-3 in a Facscan cytometer 
(Becton Dickinson) equipped with a standard filter set for green 
(530/30 nm) and orange (585/42 nm) emission. Maximum and mini- 
mum fluorescences were determined by addition of 5 laM ionomycin 
or 800 laM MgC12 before reading fluorescence intensity. 
3. Results and discussion 
Several SH-SY5Y neuroblastoma cell lines have been estab- 
lished, expressing either wild-type Cu,ZnSOD or G93A. SH- 
SY5Y cells constitutively express Bcl-2 [21], which is known to 
inhibit apoptosis without altering intracellular free Ca 2+ [22]. 
This fact could be of help in establishing a model where over- 
123 4 5 6 7  
100-  
80-  
i 
60-  
I,I. 
._J 
U. 
40. 
20, 
-'11- SH-SY5Y 
--~ WILD-TYPE 
-0-93 B 
-0-93 C 
val inomycine (I.LM) 
Fig. 2. Depolarization of mitochondria membranes by increasing 
concentrations of valinomycin, determined by JC-I fluorescence 
shift. Mean values_+ S.D. are reported; n = 3. 
expression of the mutant enzyme might have led to rapid 
apoptosis and cell death. Many clones which had overcome 
the initial selection by geneticin did not survive in long-term 
culture: those lines might represent events in which overex- 
pression of several copies of mutant SODs resulted in exces- 
sive damage and rapid cell death. We were able to propagate 
a total of six independent lines expressing G93A possibly at 
levels still compatible with survival of cells. However, even 
those lines quickly accumulated amage and after mainte- 
nance for 8-10 weeks in culture they were discarded and fresh 
aliquots were thawed. For further experiments we selected two 
independent monoclonal cell lines expressing mutant G93A 
(named 93B and 93C). 
The level of Cu,ZnSOD immunoreactive protein has been 
determined by Western blot analysis. Fig. 1 shows that cells 
transfected with the plasmid encoding wild-type human 
Cu,ZnSOD possess a significantly higher content of immuno- 
reactive nzyme as compared to untransfected SH-SY5Y cells. 
This is true also for lines 93B and 93C, where the mutants 
enzymes are expressed in a ratio close to 1:1 with the endog- 
enous wild-type protein, a situation similar to that observed in 
heterozygous FALS patients. Total superoxide dismutase ac- 
tivity roughly matches the immunoreactive protein (Table 1), 
as expected on the basis of previous reports indicating that 
FALS SOD mutant G93A retains full SOD activity [23]. 
It has been demonstrated [24] that Cu,ZnSOD has a sec- 
Fig. 1. Western blot analysis of 80 gg total protein from cell ex- 
tracts from untransfected SH-SY5Y cells (control, lane 4), cells 
transfected with wild-type Cu,ZnSOD (lane 7) or with mutant 
Cu,ZnSOD (93 B, lane 5; 93 C, lane 6). Lanes 1-3 contained puri- 
fied recombinant human Cu,ZnSOD (50, 100 and 200 lag, respec- 
tively). 
Table 1 
Cell line SOD activity SOD immunoreactive 
(U/rag total protein) protein (arbitrary units) 
SH-SY5Y 10.4_ + 1.2 n=6 100 
Wild-type 22.6 + 1.2 n = 4 230 
93 B 21.5_+3.3 n=4 210 
93 C 17.7_+1.9 n=4 170 
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ondary, one-electron peroxidase ctivity having as substrates 
H20 2 and anionic molecules, including some neurotransmit- 
ters such as glutamate and taurine, which become free radicals 
by the peroxidase reaction. Some FALS mutants, including 
G93A, have higher rates than wild-type SODI in this reaction 
[23,25,26]. Mitochondria are a major cellular source of H202 
[27], but they also represent a preferred target of this putative 
peroxidase reaction [28] due to the presence of sensitive lipids 
in their membranes. Peroxidative attack results in further pro- 
duction of H2(12 by the damaged respiratory chain. This vi- 
cious cycle ultimately results in mitochondrial swelling, un- 
coupling of oxidative phosphorylation, lipoperoxidation and 
dissipation of the Ca 2+ gradient [29]. Indeed, transgenic mice 
carrying FALS mutation G37R present mitochondrial dam- 
age, selectively localized in neurons and uniformly absent in 
other non-neuronal cell types (i.e. glia) [10] despite signifi- 
cantly elevated free radical scavenging activity. When ana- 
lyzed by staining with fluorochrome JC-1, our lines expressing 
mutant G93A showed a significant decrease in mitochondrial 
membrane potential compared with both the parental ine SH- 
SY5Y and cells expressing wild-type SOD (Fig. 2). When 
depolarization of membranes was induced by increasing doses 
of valinomycin, lines 93B and 93C showed a higher sensitivity 
to this drug than both control cell lines (SH-SY5Y and WTI. 
The expected alteration in the long-term storage of calcium 
in damaged mitochondria of cells carrying mutated Cu,Zn- 
SODs was indeed indicated by the net increase of cytosolic 
Ca ~ concentration determined by fluo-3AM staining (Table 
2). Again, this increase was found to be specific for cell lines 
expressing FALS-type mutants and was not related to total 
superoxide dismutase activity. 
Both effects observed in our cell lines, damage of mitochon- 
drial membrane and cytosolic Ca 2+ increase, might offer a 
rationale for the highly selective vulnerability of the cortico- 
neuronal system in ALS. There is compelling evidence that 
free radicals together with increases in cytosolic Ca 2+ play a 
major role in neuronal death, although neither the source of 
these radicals nor the direct connection between Ca 2+ mo- 
bilization and radical production has been conclusively iden- 
tified [30]. Ca'-' + buffering potential in the cytosol seems to be 
crucial in determining the selective vulnerability to insults of 
certain populations of cells. Only trace amounts of immuno- 
reactivity to the calcium buffering proteins calbindin-D28k 
and parvalbumin can be observed in human motoneurons 
[7] and this immunoreactivity is absent in motoneurons dam- 
aged early or severely in human ALS [31,32]. This process of 
neuronal injury may be self-sustaining. Elevation of cytosolic 
Ca ~' levels may compromise the structural integrity of mito- 
chondria; it has been demonstrated that exposure to elevated 
Ca ~+ induces production of free radicals in isolated mitochon- 
dria [30]. This could lead, in turn, to enhanced mitochondrial 
release of OH" radicals and other reactive oxygen species. 
Our data point to mitochondrial damage and Ca ~+ levels as 
early factors in the pathogenesis of FALS. Whether mutations 
Table 2 
Cell line Cytosolic Ca 2. concentration ( M) 
SH-SY5Y 187 _+ 7 n = 8 
Wild-type 198 + 13 n = 5 
93 B 263-+22 n=6 
93 C 261 +23 n=4 
in Cu,ZnSOD induce this damage through generation of OH" 
or other reactive species remains to be clarified and needs 
further investigation. 
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